Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,318.50
Bid: 1,317.50
Ask: 1,318.50
Change: 36.00 (2.81%)
Spread: 1.00 (0.076%)
Open: 1,296.00
High: 1,321.00
Low: 1,296.00
Prev. Close: 1,282.50
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CEO Appointment

26 Feb 2019 07:00

RNS Number : 0726R
Persimmon PLC
26 February 2019
 

26 February 2019

 

Persimmon plc

("Persimmon" or "the Company")

 

 

David Jenkinson appointed Group Chief Executive

 

Persimmon plc announces today that following a detailed search process, David Jenkinson has been appointed Group Chief Executive with immediate effect.

 

Dave was appointed interim CEO in November 2018. Dave has been with Persimmon in a number of roles for 22 years, most recently as Group Managing Director, and has been instrumental in the development and implementation of many of the successful operational initiatives which have underpinned the Group's robust performance in recent years. He has been a member of the Persimmon board for over five years, with particular responsibility for land purchase.

 

Roger Devlin, Persimmon's Chairman, said: "After a thorough search, both within the housebuilding sector and more widely, it was clear to the Board that Dave was the best candidate for the role. Since his appointment as interim CEO last year Dave has shown both strong leadership in maintaining the Company's track record of operational excellence but also that he is listening carefully to the views of all our stakeholders. Persimmon remains committed to its goal of being the leading volume builder of good value, traditional family homes throughout the UK." 

 

David Jenkinson said: "Persimmon is a great company with a bright future and I am honoured to have been asked to lead it. My priorities will be to maintain the strong operational and financial momentum of the business, to develop further our customer care operations and to bring a greater focus to our wider responsibilities as a leading UK house builder. We have a strong and committed team and I look forward to continuing to work with all my colleagues to deliver the high quality, attractively priced homes that the UK needs."

 

Remuneration Arrangements

 

Dave Jenkinson has agreed that there will be no change to his remuneration upon his appointment as Group Chief Executive. It has also been agreed that Dave will not participate in annual bonus arrangements in 2019 and will not receive an award under the Group's 2017 Share Performance Plan. As previously announced, Dave's remuneration did not change when he was appointed interim Group Chief Executive. The Remuneration Committee expects to implement a new remuneration package for Dave from 1 January 2020, we expect to consult with major shareholders on this in autumn 2019.

 

The Company has today separately announced its full year results for the year ended 31 December 2018. 

 

This announcement contains inside information. 

 

Classification: Inside information

 

Further information, please contact:

Persimmon plc

Citigate Dewe Rogerson

Roger Devlin, Chairman

Simon Rigby / Kevin Smith

Tel: +44 (0)1904 642199

Tel: +44 (0)20 7638 9571

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPGUWWPUPBPUA
Date   Source Headline
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:12 pmRNSTotal Voting Rights
22nd Sep 20223:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.